Introduction of pro-interleukin-16 inhibits T-lymphoblastic leukemia growth in mice
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Pro-interleukin-16 (pro-IL-16) is the precursor to mature interleukin-16 (IL-16) protein. Previous studies have demonstrated that pro-IL-16 can function as a regulator of cell cycle. A number of human T-cell leukemia and lymphoma cell lines are pro-IL-16 deficient. Intracellular expression of pro-IL-16 causes these cell lines to become quiescent, implicating loss of pro-IL-16 as a contributory step in T-cell malignancy. Therefore, we tested whether or not reintroduction of pro-IL-16 into solid tumors in mice could halt tumor growth.
MOLT-4 lymphoblastic leukemia cells were stably transfected with a dsRed-tomato virus and were injected subcutaneously into NOD/SCID/γ chain-knockout mice. Tumor growth was monitored with an in vivo imaging system. A pro-IL-16-GFP fusion virus or control GFP only virus was injected into the tumors, and mice were monitored for 1 week.
Injection of the pro-IL-16-containing lentivirus inhibited growth of established MOLT-4 tumors in mice. Tumor explants exhibited diminished proliferative capacity.
Our data support the concept that restoration of pro-IL-16 expression in malignant T cells may have therapeutic value.
- Carrano AC, Eytan E et al (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1(4):193–199 CrossRef
- Center DM, Cruikshank W (1982) Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol 128(6):2563–2568
- Center DM, Cruikshank WW et al (2004) Nuclear pro-IL-16 regulation of T cell proliferation: p27(KIP1)-dependent G0/G1 arrest mediated by inhibition of Skp2 transcription. J Immunol 172(3):1654–1660
- Cruikshank W, Center DM (1982) Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J Immunol 128(6):2569–2574
- Cruikshank WW, Berman JS et al (1987) Lymphokine activation of T4 + T lymphocytes and monocytes. J Immunol 138(11):3817–3823
- Cruikshank WW, Center DM et al (1994) Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci USA 91(11):5109–5113 CrossRef
- Cruikshank WW, Kornfeld H et al (2000) Interleukin-16. J Leukoc Biol 67(6):757–766
- Lynch EA, Heijens CA et al (2003) Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5. J Immunol 171(10):4965–4968
- Muhlhahn P, Zweckstetter M et al (1998) Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site. Nat Struct Biol 5(8):682–686 CrossRef
- Ohsugi Y, Gershwin ME et al (1980) Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X-irradiated nude mice. J Natl Cancer Inst 65(4):715–718
- Richmond J, Tuzova M et al (2011) Interleukin-16 as a marker of Sezary syndrome onset and stage. J Clin Immunol 31(1): 39–50
- Tsvetkov LM, Yeh KH et al (1999) p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 9(12):661–664 CrossRef
- Watanabe S, Shimosato Y et al (1980) Transplantability of human lymphoid cell line, lymphoma, and leukemia in splenectomized and/or irradiated nude mice. Cancer Res 40(7):2588–2595
- Zhang Y, Tuzova M et al (2008) Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP. J Immunol 180(1):402–408
- Introduction of pro-interleukin-16 inhibits T-lymphoblastic leukemia growth in mice
Journal of Cancer Research and Clinical Oncology
Volume 137, Issue 10 , pp 1581-1585
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Growth arrest
- Malignant T cell
- Lymphoblastic leukemia
- Lentiviral vector
- Industry Sectors